162 related articles for article (PubMed ID: 6196200)
1. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against human astrocytomas and their reactivity pattern.
Stavrou D; Keiditsch E; Schmidberger F; Bise K; Funke I; Eisenmenger W; Kurrle R; Martin B; Stocker U
J Neurol Sci; 1987 Sep; 80(2-3):205-20. PubMed ID: 3316507
[TBL] [Abstract][Full Text] [Related]
3. Presence and absence of virus particles in hybridomas secreting monoclonal antibodies against gliomas.
Stavrou D; Bilzer T; Tsangaris T; Dürr E; Steinecke M; Anzil AP
J Cancer Res Clin Oncol; 1983; 106(1):77-80. PubMed ID: 6885900
[TBL] [Abstract][Full Text] [Related]
4. Derivation of a brain tumor-selective monoclonal antibody from hybridoma between mouse myeloma and rat spleen cells immune to syngeneic glioma.
Saya H; Masuko T; Hashimoto Y
Jpn J Cancer Res; 1985 Dec; 76(12):1198-202. PubMed ID: 3937832
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
6. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG.
Wikstrand CJ; Bigner SH; Bigner DD
J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821
[TBL] [Abstract][Full Text] [Related]
7. Chemical modification and antigenicity of glioma cells.
Stavrou D; Hultén M; Bilzer T
Acta Neuropathol Suppl; 1981; 7():75-8. PubMed ID: 6164240
[TBL] [Abstract][Full Text] [Related]
8. Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence.
Fischer DK; Matsuda M; Shaban F; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():263-70. PubMed ID: 1805570
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of experimental glioma grafts by monoclonal antibody treatment.
Stavrou D; Mellert W; Mellert U; Keiditsch E; Bise K; Mehraein P
J Cancer Res Clin Oncol; 1986; 112(2):111-8. PubMed ID: 3771619
[TBL] [Abstract][Full Text] [Related]
10. The humoral antibody response of rats immunized with chemically modified syngeneic brain cells and glioma cells.
Stavrou D; Hultén M; Anzil AP; Bilzer T
Int J Cancer; 1980 Nov; 26(5):629-37. PubMed ID: 7239719
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies specific for two different histological types of human lung carcinoma.
Saji S; Zylstra S; Schepart BS; Ghosh SK; Jou YH; Takita H; Bankert RB
Hybridoma; 1984; 3(2):119-29. PubMed ID: 6090307
[TBL] [Abstract][Full Text] [Related]
12. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and characterization of monoclonal antibodies against Clonorchis sinensis].
Pan S; Zhou J; Huang J; Huang Z; Ruan C; Pan P
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(1):42-4. PubMed ID: 12078207
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies in neuro-oncology.
Stavrou D
Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
[TBL] [Abstract][Full Text] [Related]
15. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
[TBL] [Abstract][Full Text] [Related]
17. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
18. Hybridoma antibody to breast cancer immune complexes.
Papsidero LD; Nemoto T; Valenzuela L; Chu TM
Hybridoma; 1982; 1(3):275-82. PubMed ID: 6765320
[TBL] [Abstract][Full Text] [Related]
19. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
20. Human glioma-specific antigens detected by monoclonal antibodies.
Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
